Total Holdings
51
Portfolio diversification across 51 positions
FTXH
(NASDAQ)First Trust Nasdaq Pharmaceuticals ETF
$38.83-- (--)
Loading... - Market loading
FTXH ETF Holdings: First Trust Nasdaq Pharmaceuticals ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$34.19M
Total fund assets
Expense Ratio
0.60%
Annual management fee
Fund Issuer
First Trust
Nasdaq Stock Market
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Eli Lilly and Company | Stock | 7.80% |
| 2 |  | Bristol-Myers Squibb Company | Stock | 7.20% |
| 3 |  | Merck & Co., Inc | Stock | 7.06% |
| 4 |  | Johnson & Johnson | Stock | 7.03% |
| 5 |  | AbbVie Inc | Stock | 6.97% |
| 6 |  | Viatris Inc | Stock | 4.16% |
| 7 |  | Biogen Inc. | Stock | 3.76% |
| 8 |  | Cardinal Health, Inc. | Stock | 3.59% |
| 9 |  | Pfizer Inc | Stock | 3.54% |
| 10 |  | Gilead Sciences, Inc | Stock | 3.30% |
| 11 |  | Vertex Pharmaceuticals Incorporated | Stock | 3.30% |
| 12 |  | Amgen Inc. | Stock | 3.28% |
| 13 |  | United Therapeutics Corporation | Stock | 3.15% |
| 14 |  | Regeneron Pharmaceuticals, Inc | Stock | 3.10% |
| 15 |  | Jazz Pharmaceuticals plc | Stock | 2.73% |
| 16 |  | Zoetis Inc | Stock | 2.30% |
| 17 |  | Incyte Corporation | Stock | 2.30% |
| 18 |  | Illumina, Inc. | Stock | 2.01% |
| 19 |  | Exelixis, Inc. | Stock | 1.79% |
| 20 |  | Neurocrine Biosciences, Inc | Stock | 1.40% |
| 21 |  | PTC Therapeutics, Inc. | Stock | 1.38% |
| 22 |  | Medpace Holdings, Inc. | Stock | 1.33% |
| 23 |  | Charles River Laboratories International, Inc. | Stock | 1.32% |
| 24 |  | Alkermes plc | Stock | 1.22% |
| 25 |  | Halozyme Therapeutics, Inc | Stock | 1.17% |
| 26 |  | BioMarin Pharmaceutical Inc | Stock | 1.17% |
| 27 |  | Spyre Therapeutics Inc. | Stock | 0.90% |
| 28 |  | Elanco Animal Health Incorporated | Stock | 0.79% |
| 29 |  | Travere Therapeutics Inc | Stock | 0.78% |
| 30 |  | Catalyst Pharmaceuticals Inc | Stock | 0.70% |
| 31 |  | TG Therapeutics, Inc | Stock | 0.68% |
| 32 |  | Arrowhead Pharmaceuticals, Inc | Stock | 0.67% |
| 33 |  | Guardant Health, Inc | Stock | 0.65% |
| 34 |  | Twist Bioscience Corporation | Stock | 0.65% |
| 35 |  | Arcus Biosciences, Inc | Stock | 0.61% |
| 36 |  | Ligand Pharmaceuticals Incorporated | Stock | 0.58% |
| 37 |  | Protagonist Therapeutics Inc | Stock | 0.57% |
| 38 |  | Krystal Biotech, Inc | Stock | 0.57% |
| 39 |  | Mirum Pharmaceuticals Inc | Stock | 0.57% |
| 40 |  | 10x Genomics, Inc | Stock | 0.56% |
| 41 |  | Roivant Sciences Ltd | Stock | 0.55% |
| 42 |  | Amneal Pharmaceuticals, Inc | Stock | 0.55% |
| 43 |  | Ionis Pharmaceuticals, Inc | Stock | 0.48% |
| 44 |  | Alnylam Pharmaceuticals, Inc | Stock | 0.47% |
| 45 |  | Supernus Pharmaceuticals, Inc | Stock | 0.47% |
| 46 |  | Kymera Therapeutics, Inc | Stock | 0.46% |
| 47 |  | Moderna, Inc | Stock | 0.46% |
| 48 |  | ACADIA Pharmaceuticals Inc | Stock | 0.45% |
| 49 |  | Tarsus Pharmaceuticals Inc | Stock | 0.44% |
| 50 |  | Arcutis Biotherapeutics, Inc | Stock | 0.40% |
Frequently Asked Questions About First Trust Nasdaq Pharmaceuticals ETF Holdings
What are the top holdings in FTXH?
First Trust Nasdaq Pharmaceuticals ETF (FTXH) holds 51 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is FTXH's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review FTXH's holdings table to analyze concentration risk.
What is FTXH's sector allocation?
The Sector Allocation chart shows how FTXH distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does FTXH invest in?
FTXH's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is FTXH ETF?
FTXH's diversification can be assessed by reviewing its 51 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.